Short- and Long-term Effects of Robot-assisted Plication in Diaphragmatic Paralysis
Launched by UPPSALA COUNTY COUNCIL, SWEDEN · Apr 1, 2025
Trial Information
Current as of July 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a surgical procedure called robot-assisted diaphragmatic plication, which aims to help patients who have difficulty breathing due to a condition known as diaphragmatic paralysis. This condition can cause severe symptoms like breathlessness and limits physical activity. The trial will look at how effective this surgery is in improving breathing, physical performance, and overall lung function over both short and long periods of time. Researchers will track patients' progress at five hospitals in Sweden, assessing them before and after the surgery at different intervals up to three years.
To participate, you need to be between 18 and 75 years old and have been experiencing symptoms from diaphragmatic paralysis for at least a year. You’ll be scheduled for the surgery if you meet the criteria and can complete forms in Swedish. The trial is not yet recruiting participants, but if you join, you can expect regular check-ups to monitor your breathing and health after the surgery. This study is important because it will provide more information on the benefits of this minimally invasive surgery, helping doctors better understand how to treat patients with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with symptomatic unilateral diaphragmatic paralysis persisting for ≥1 year
- • Patients are scheduled for RATS at thoracic surgery clinics in five Swedish university hospitals (Gothenburg, Linköping, Lund, Umeå, and Uppsala).
- Exclusion Criteria:
- • Inability to complete forms in Swedish
- • Neuromuscular disease as the cause of diaphragmatic paralysis
- • Other significant causes of dyspnea
- • Impaired physical capacity from other causes than diaphragmatic paralysis.
About Uppsala County Council, Sweden
Uppsala County Council, based in Sweden, serves as a pivotal sponsor for clinical trials, dedicated to advancing healthcare through innovative research and evidence-based practices. With a focus on enhancing patient care within the region, the council collaborates with academic institutions, healthcare providers, and industry partners to facilitate the development and evaluation of new therapies and medical interventions. Upholding rigorous ethical standards and regulatory compliance, Uppsala County Council is committed to fostering a research environment that prioritizes patient safety and the generation of high-quality scientific data, ultimately contributing to improved health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uppsala, , Sweden
Patients applied
Trial Officials
Andreas Palm, Md, PhD
Principal Investigator
Uppsala University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported